BioLineRx Presents Positive Safety and Efficacy Results for Novel Stem-Cell … – MarketWatch
|
BioLineRx Presents Positive Safety and Efficacy Results for Novel Stem–Cell …
MarketWatch Robust stem–cell mobilization was evident in all treated participants across the different doses tested, leading to a median 9.5-fold increase of stem cells in the peripheral blood following a single BL-8040 treatment. Two to four hours after a single … |
